Dr. Reddy's Laboratories Limited (NSE:DRREDDY)
India · Delayed Price · Currency is INR 1,173.00
+30.00 (2.62%)
Sep 11, 2026, 3:14 PM IST
Dr. Reddy's Laboratories Market Cap
Dr. Reddy's Laboratories has a market cap or net worth of 967.09 billion as of September 11, 2026. Its market cap has decreased by -10.91% in one year.
Market Cap
967.09B
Enterprise Value
960.93B
Revenue
331.19B
Ranking
n/a
PE Ratio
29.21
Stock Price
1,173.00
ChartMarket Cap Chart
Since May 31, 1999, Dr. Reddy's Laboratories's market cap has increased from 21.00B to 967.09B, an increase of 4,504.25%. That is a compound annual growth rate of 15.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 11, 2026 | 967.09B | -8.61% |
| Dec 31, 2025 | 1.06T | -8.50% |
| Dec 31, 2024 | 1.16T | 19.80% |
| Dec 29, 2023 | 965.41B | 37.28% |
| Dec 30, 2022 | 703.23B | -13.66% |
| Dec 31, 2021 | 814.50B | -5.67% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Divi's Laboratories | 2.47T |
| Zydus Lifesciences | 1.12T |
| Cipla | 1.10T |
| Laurus Labs | 1.06T |
| Aurobindo Pharma | 966.52B |
| Mankind Pharma | 941.63B |
| Glenmark Pharmaceuticals | 682.70B |
| Alkem Laboratories | 608.29B |